Compton Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,973
| Closed | -$423K | – | 34 |
|
|
2023
Q1 | $423K | Sell |
3,973
-7,840
| -66% | -$846K | 0.91% | 30 |
|
|
2022
Q4 | $1.31M | Sell |
11,813
-880
| -7% | -$90K | 0.95% | 30 |
|
|
2022
Q3 | $1.09M | Sell |
12,693
-1,584
| -11% | -$141K | 0.73% | 37 |
|
|
2022
Q2 | $1.3M | Sell |
14,277
-10,748
| -43% | -$953K | 0.72% | 35 |
|
|
2022
Q1 | $2.05M | Hold |
25,025
| – | – | 0.57% | 45 |
|
|
2021
Q4 | $1.92M | Buy |
25,025
+734
| +3% | +$58.5K | 0.5% | 50 |
|
|
2021
Q3 | $1.82M | Buy |
24,291
+1,450
| +6% | +$110K | 0.54% | 47 |
|
|
2021
Q2 | $1.78M | Sell |
22,841
-1,844
| -7% | -$137K | 0.52% | 49 |
|
|
2021
Q1 | $1.82M | Buy |
24,685
+1,048
| +4% | +$77.3K | 0.57% | 46 |
|
|
2020
Q4 | $1.84M | Buy |
23,637
+703
| +3% | +$53.8K | 0.62% | 43 |
|
|
2020
Q3 | $1.81M | Hold |
22,934
| – | – | 0.7% | 42 |
|
|
2020
Q2 | $1.69M | Buy |
22,934
+576
| +3% | +$43.4K | 0.71% | 45 |
|
|
2020
Q1 | $1.64M | Sell |
22,358
-168
| -0.7% | -$13.2K | 0.81% | 43 |
|
|
2019
Q4 | $1.96M | Sell |
22,526
-125
| -0.6% | -$10.3K | 0.76% | 47 |
|
|
2019
Q3 | $1.82M | Sell |
22,651
-1,499
| -6% | -$120K | 0.76% | 48 |
|
|
2019
Q2 | $1.93M | Buy |
24,150
+576
| +2% | +$44.1K | 0.82% | 45 |
|
|
2019
Q1 | $1.87M | Sell |
23,574
-136
| -0.6% | -$10.2K | 0.81% | 44 |
|
|
2018
Q4 | $1.73M | Hold |
23,710
| – | – | 0.83% | 46 |
|
|
2018
Q3 | $1.6M | Sell |
23,710
-63
| -0.3% | -$4.01K | 0.63% | 53 |
|
|
2018
Q2 | $1.38M | Hold |
23,773
| – | – | 0.58% | 55 |
|
|
2018
Q1 | $1.24M | Sell |
23,773
-52
| -0.2% | -$2.81K | 0.52% | 65 |
|
|
2017
Q4 | $1.28M | Buy |
23,825
+1,572
| +7% | +$87.1K | 0.55% | 61 |
|
|
2017
Q3 | $1.36M | Sell |
22,253
-19
| -0.1% | -$1.15K | 0.61% | 56 |
|
|
2017
Q2 | $1.36M | Buy |
22,272
+1,274
| +6% | +$77.6K | 0.62% | 53 |
|
|
2017
Q1 | $1.27M | Buy |
20,998
+236
| +1% | +$14.3K | 0.63% | 52 |
|
|
2016
Q4 | $1.17M | Sell |
20,762
-20,343
| -49% | -$1.19M | 0.61% | 53 |
|
|
2016
Q3 | $2.35M | Buy |
41,105
+20,762
| +102% | +$1.21M | 0.65% | 49 |
|
|
2016
Q2 | $1.12M | Buy |
20,343
+419
| +2% | +$22.3K | 0.62% | 52 |
|
|
2016
Q1 | $1.01M | Hold |
19,924
| – | – | 0.57% | 55 |
|
|
2015
Q4 | $1M | Buy |
19,924
+262
| +1% | +$13.2K | 0.57% | 55 |
|
|
2015
Q3 | $927K | Buy |
19,662
+105
| +0.5% | +$5.58K | 0.33% | 55 |
|
|
2015
Q2 | $1.06M | Buy |
19,557
+2,023
| +12% | +$113K | 0.58% | 51 |
|
|
2015
Q1 | $962K | Sell |
17,534
-136
| -0.8% | -$7.7K | 0.54% | 56 |
|
|
2014
Q4 | $958K | Sell |
17,670
-158
| -0.9% | -$8.8K | 0.52% | 56 |
|
|
2014
Q3 | $1.01M | Sell |
17,828
-10
| -0.1% | -$562 | 0.55% | 55 |
|
|
2014
Q2 | $985K | Buy |
17,838
+206
| +1% | +$11.2K | 0.53% | 57 |
|
|
2014
Q1 | $955K | Sell |
17,632
-155
| -0.9% | -$8.03K | 0.55% | 55 |
|
|
2013
Q4 | $849K | Buy |
17,787
+384
| +2% | +$17.6K | 0.48% | 59 |
|
|
2013
Q3 | $791K | Hold |
17,403
| – | – | 0.48% | 60 |
|
|
2013
Q2 | $771K | Buy |
+17,403
| New | +$777K | 0.48% | 60 |
|
Other funds holding MRK
Compton Capital Management's MRK Position: Q2 2023 in Review
Compton Capital Management sold out of Merck (MRK) in Q2 2023, closing a stake of 3,973 shares — an estimated $423K sold.
Compton Capital Management first reported a position in MRK in Q2 2013 and held it in 40 quarters. The position peaked at $2.35M in Q3 2016. 3,256 funds tracked by Wall St. Rank hold MRK as of Q2 2023.
- Compton Capital Management reported no remaining Merck position as of Q2 2023 after selling out during the quarter.
- Compton Capital Management sold 3,973 Merck shares in Q2 2023, an estimated $423K.
- Compton Capital Management first reported a position in Merck in Q2 2013 and held it in 40 quarters.
- Compton Capital Management's Merck position peaked at $2.35M in Q3 2016.
- 3,256 funds tracked by Wall St. Rank held Merck as of Q2 2023.
Based on Compton Capital Management's 13F filing for Q2 2023, filed 9 Aug 2023.